See whether Helium helps you make better-informed decisions. Try every Pro Trader feature for 30 days. No credit card required.
Try every Pro Trader feature for 30 days. No credit card required.
Neutral-to-slightly optimistic assessment of LLM performance in informed consent, reporting high accuracy/readability with caveats on tone, context awareness, and empathy, indicating cautious, evidence-based appraisal rather than hype.
Proof-of-concept study evaluating trial-specific LLM performance in informed consent for a randomized clinical trial, including human and LLM evaluations and a second LLM for reproducibility of accuracy assessments.
Text-limited; cautious, evidence-based; avoid assumptions beyond provided data.
2026 © Helium Trades
Privacy Policy & Disclosure
* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy
of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions,
you should consult a financial expert before engaging in any transaction.